EXEL (STOCKS)
Exelixis Inc
$53.211900
+0.081900 (+0.15%)
Prev close: $53.130000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Michael M. Morrissey
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $13,326.85M
- Employees
- 1,147
- P/E (TTM)
- 17.61
- P/B (TTM)
- 6.96
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
9
Buy
10
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.79 | $0.72 | +0.0723 | +10.07% |
|
Dec 2025 (Q4)
|
$0.88 | $0.82 | +0.0579 | +7.04% |
|
Sep 2025 (Q3)
|
$0.69 | $0.63 | +0.0586 | +9.28% |
|
Jun 2025 (Q2)
|
$0.65 | $0.57 | +0.0798 | +14.00% |
Financial Statements
| Assets | $2.59B |
| Current Assets | $1.21B |
| Accounts Receivable | $328.95M |
| Inventory | $26.61M |
| Other Current Assets | $853.09M |
| Noncurrent Assets | $1.38B |
| Fixed Assets | $95.52M |
| Other Non-current Assets | $1.29B |
| Liabilities | $657.85M |
| Current Liabilities | $370.98M |
| Accounts Payable | $24.15M |
| Other Current Liabilities | $346.82M |
| Noncurrent Liabilities | $286.87M |
| Equity | $1.94B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.94B |
| Liabilities And Equity | $2.59B |